BridgeMD
New treatment option for Acute Heart Failure (AHF)
Official title Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure
ClinicalTrials.gov ID: NCT07099885
What this study is testing
- What it's testing
- The aim of this study is to evaluate the effectiveness of loop diuretic adaptative algorithm that is based on machine learning, urine output prediction tool, in decongestion of acute heart failure patients. A total of 90 patients will be enrolled in the study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients over 18 years of age who provide informed consent
- Ability to enroll in the study within the first 24 hours of hospitalization
- Primary reason for hospitalization is acute heart failure with signs of congestion (at least moderate lower extremity edema)
- NT-proBNP \> 1500 pg/ml
- Anticipated need for diuretic therapy for at least 48 hours from the time of study enrollment
You likely can't join if
- End-stage kidney disease requiring renal replacement therapy
- Hemodynamic instability requiring inotropic support
- Active infection requiring intravenous antibiotic therapy
The study team makes the final eligibility decision.
Where it's taking place
- Wroclaw, Dolnosląskie, Poland
- Wroclaw, Lower Silesian Voivodeship, Poland
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wroclaw, Dolnosląskie, Poland; Wroclaw, Lower Silesian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.